Home > Healthcare > Medical Devices > Therapeutic Devices > Intravenous Infusion Pump Market

Intravenous Infusion Pump Market Share

Report ID: GMI5528
Published Date: Mar 2023
Report Format: PDF

Download Free Sample

Intravenous Infusion Pump Market Share

The competitive landscape of the intravenous infusion pump market comprises companies such as :

F. Hoffmann-La Roche Ltd.
Boston Scientific Corporation
Fresenius Kabi
Moog Inc.
Terumo Corporation
Tandem Diabetes Care, Inc.
Micrel Medical Devices SA
Shenzhen ENMIND Technology Co., Ltd.
Medtronic
ICU Medical
IRadimed Corporation
Becton
Dickinson and Company, B.
Braun Melsungen AG
and Baxter International Inc.

Product portfolio expansions and collaborations are some of the key initiatives being undertaken by these companies to reinforce their market presence.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for intravenous infusion pump exceeded USD 5.5 billion in 2022 and will depict over 5% CAGR through 2023-2032, as a result of the growing prevalence of cancer and other chronic diseases.

Syringe product segment is slated to reach over USD 3 billion by 2032, owing to the product’s application scope as an excellent medicine delivery method for palliative care.

North America region held a 36% share of the intravenous infusion pump industry over 2023-2032, due to the high prevalence of bleeding disorders including hemophilia.

Key players in the intravenous infusion pump market include F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Medtronic, ICU Medical, Becton, Dickinson and Company, B. Braun Melsungen AG, and Baxter International Inc., among others.